Franklin M. Berger, Director at Kezar Life Sciences, Inc. (KZR), bought 241,692 shares at $2.60 ($628K) on 2020-02-04, disclosed to the SEC on 2020-02-05.
Open-market purchase of $628k KZR by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.60 | 120,846 | $314K | 50.0% |
| 2 | $2.60 | 120,846 | $314K | 50.0% |
| Total | $2.60 avg | 241,692 | $628K | 100% |
| Filing → |
| EPIX | BUY | 2023-11-22 | $267K | — | Filing → |
| EPIX | BUY | 2023-11-16 | $518K | — | Filing → |
| EPIX | SELL | 2023-01-05 | $1.0M | — | Filing → |